<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Melanoma_in_Congenital_Melanocytic_Nevus - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-name-link {
            color: inherit;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
        }

        .item-name-link:hover {
            text-decoration-thickness: 2px;
        }

        .missing-disease-name {
            color: #991b1b;
            border-bottom: 1px dotted #dc2626;
        }

        .curation-gap-badge {
            display: inline-flex;
            align-items: center;
            margin-left: 8px;
            padding: 2px 8px;
            border-radius: 999px;
            font-size: 0.72rem;
            font-weight: 700;
            letter-spacing: 0.01em;
            text-transform: uppercase;
            background: #fef2f2;
            border: 1px solid #fecaca;
            color: #b91c1c;
            vertical-align: middle;
        }

        .missing-ontology-link {
            color: #b91c1c !important;
            text-decoration: underline dotted;
            text-underline-offset: 2px;
        }

        .dismech-inline-link {
            margin-left: 6px;
            font-size: 0.78rem;
            font-weight: 600;
            color: #0369a1;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
            white-space: nowrap;
        }

        .dismech-inline-link:hover {
            text-decoration-thickness: 2px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "‚Ü≥ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Melanoma_in_Congenital_Melanocytic_Nevus</span>
        </nav>

        <header class="page-header">
            <h1>Melanoma_in_Congenital_Melanocytic_Nevus</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Skin Cancer</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0850110" target="_blank">
                        MONDO:0850110
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Congenital Melanocytic Nevus</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Melanoma</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#histopathology">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Histopathology</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">8</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">8</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">cancer</span>
                    
                    <span class="tag tag-classification">solid tumor</span>
                    
                </div>
            </div>
            
            
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">ICD-O Morphology</div>
                <div class="tag-list">
                    <span class="tag tag-classification">Melanoma</span>
                </div>
            </div>
            
            
            
            
        </div>
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Genetic Mutations</div>
                
                <div class="item-desc">Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E) occur during embryogenesis in neural crest-derived melanocyte precursors, driving constitutive MAPK signaling. NRAS mutations are dominant in large/giant CMN (68-94%), while BRAF mutations are less common. Progression to melanoma requires additional alterations including TERT activation, CDKN2A loss, TP53 mutations, and PTEN inactivation.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        melanocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000148" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        neural crest cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0011012" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        BRAF
                        
                        <a href="https://bioregistry.io/hgnc:1097" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        NRAS
                        
                        <a href="https://bioregistry.io/hgnc:7989" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        MAPK cascade
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0000165" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        cellular senescence
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0090398" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        telomere maintenance
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0000723" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        skin
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002097" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        leptomeninx
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000391" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16750612" target="_blank">PMID:16750612</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The most exciting finding is the discovery of oncogenic BRAF mutations in both malignant melanoma and melanocytic nevi. This finding indicates that activation of the mitogen-activated protein kinase pathway may be a critical initiating step of melanocytic neoplasia."</div>
                
                
                <div class="evidence-explanation">This study supports the role of BRAF mutations in the pathophysiology of melanoma in melanocytic nevi, including congenital cases.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28110826" target="_blank">PMID:28110826</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Congenital melanocytic nevus syndrome (CMNS) is the result of an abnormal proliferation of melanocytes in the skin and central nervous system caused by progenitor-cell mutations during embryonic development. Mutations in the NRAS gene have been detected in many of these cells."</div>
                
                
                <div class="evidence-explanation">This reference covers NRAS mutations in congenital melanocytic nevus syndrome but does not mention BRAF mutations.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32100974" target="_blank">PMID:32100974</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Melanomas developing on pre-existing congenital or acquired nevi are usually of the superficial spreading subtype and harbor the BRAFV600E mutation."</div>
                
                
                <div class="evidence-explanation">This study supports the presence of BRAF mutations in melanomas associated with congenital melanocytic nevi.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">UV Exposure</div>
                
                <div class="item-desc">Ultraviolet (UV) radiation can damage the DNA in skin cells, contributing to mutations and the development of melanoma.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25268584" target="_blank">PMID:25268584</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the three CNMs contained an activating NRAS Q61 mutation and no TERT-p mutations."</div>
                
                
                <div class="evidence-explanation">While the study does not explicitly link UV radiation to melanoma in congenital melanocytic nevus (CNM), it differentiates the mutational spectrum of CNMs from other types of melanoma, suggesting a distinct pathogenesis. Thus, the connection between UV radiation and CNM-related melanoma remains implicit and not clearly defined.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33759772" target="_blank">PMID:33759772</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"validated the role of ultraviolet-induced DNA mutations in melanoma formation"</div>
                
                
                <div class="evidence-explanation">This reference confirms the role of UV-induced DNA mutations in melanoma formation but does not specifically address melanoma developing from congenital melanocytic nevi.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">PI3K-AKT-mTOR Pathway Activation</div>
                
                <div class="item-desc">Compensatory activation of the PI3K-AKT-mTOR pathway occurs alongside MAPK signaling, often driven by PTEN loss. This pathway cross-talk promotes cell survival, invasion, and resistance to MEK inhibition. Combined targeting of both MAPK and PI3K pathways represents a rational therapeutic strategy.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        PTEN
                        
                        <a href="https://bioregistry.io/hgnc:9588" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        phosphatidylinositol-mediated signaling
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0048015" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        TOR signaling
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0031929" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">DNA Damage</div>
                
                <div class="item-desc">Damage to DNA structure from various causes</div>
                
                
                
                
                
                
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Uncontrolled Cell Growth</div>
                
                <div class="item-desc">Dysregulated cellular proliferation</div>
                
                
                
                
                
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        
        <div class="card" id="histopathology">
            <div class="card-header">
                <div class="card-icon" style="background: #ffedd5; color: #c2410c;">‚ú∂</div>
                <h2 class="card-title">Histopathology</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box histopathology-box">
                <div class="item-name">
                    Melanocytic Neoplasm
                    
                    <span class="histopathology-freq">VERY_FREQUENT</span>
                    
                </div>
                
                <div class="item-desc">Malignant melanoma represents a neoplasm stemming from melanocytes.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27268913" target="_blank">PMID:27268913</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Malignant melanoma represents a neoplasm stemming from melanocytes"</div>
                
                
                <div class="evidence-explanation">Abstract defines melanoma as a neoplasm stemming from melanocytes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="graph-warning">
                <strong>Referential integrity issues (2):</strong>
                <ul>
                    
                    <li>Target &#39;Malignant Transformation&#39; (from &#39;Genetic Mutations&#39;) not found in named elements</li>
                    
                    <li>Target &#39;Malignant Transformation&#39; (from &#39;PI3K-AKT-mTOR Pathway Activation&#39;) not found in named elements</li>
                    
                    
                </ul>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    DNA_Damage[&#34;DNA Damage&#34;]
    Malignant_Transformation[&#34;Malignant Transformation&#34;]
    Genetic_Mutations[&#34;Genetic Mutations&#34;]
    UV_Exposure[&#34;UV Exposure&#34;]
    PI3K_AKT_mTOR_Pathway_Activation[&#34;PI3K-AKT-mTOR Pathway Activation&#34;]
    Uncontrolled_Cell_Growth[&#34;Uncontrolled Cell Growth&#34;]

    Genetic_Mutations --&gt; Uncontrolled_Cell_Growth
    Genetic_Mutations -.-&gt; Malignant_Transformation
    UV_Exposure --&gt; DNA_Damage
    PI3K_AKT_mTOR_Pathway_Activation -.-&gt; Malignant_Transformation

    style DNA_Damage fill:#dbeafe
    style Malignant_Transformation fill:#fee2e2,stroke:#dc2626,stroke-dasharray: 5 5
    style Genetic_Mutations fill:#dbeafe
    style UV_Exposure fill:#dbeafe
    style PI3K_AKT_mTOR_Pathway_Activation fill:#dbeafe
    style Uncontrolled_Cell_Growth fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">8</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Integument<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Nervous System<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Other<span class="pill-count">(4)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Lymphadenopathy
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002716" target="_blank">
                                Lymphadenopathy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002716)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Swollen lymph nodes may indicate metastasis</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38779794" target="_blank">PMID:38779794</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A 30-year-old female patient presented with a swelling of a cervical left lymph node measuring 1x3 cm, which had been presenting for three weeks. Lymph node excision revealed a metastasis of a malignant melanoma."</div>
                
                
                <div class="evidence-explanation">The swollen lymph nodes indicating metastasis, with the subject having melanoma, supports the statement of lymphadenopathy as an occasional systemic phenotype of melanoma-in-congenital-melanocytic-nevus.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14750241" target="_blank">PMID:14750241</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Melanocytic nevi occurring in lymph nodes create diagnostic difficulty by mimicking metastases. Few studies describe nodal nevi in sentinel lymph nodes (SLNs) excised for melanoma."</div>
                
                
                <div class="evidence-explanation">While this source discusses lymph nodes in relation to melanoma, the focus is more on diagnostic difficulty rather than a clear statement of lymphadenopathy as a phenotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11902552" target="_blank">PMID:11902552</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Lymph-node metastasis is an indicator of poor prognosis for patients with melanoma."</div>
                
                
                <div class="evidence-explanation">Lymph-node metastasis being a poor prognosis indicator supports the link between swollen lymph nodes and metastasis in melanoma patients, supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Integument
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Pruritus
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000989" target="_blank">
                                Pruritus
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000989)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Itching of the lesion can sometimes occur</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (10 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29971818" target="_blank">PMID:29971818</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We report a 6-year-old child with molluscum contagiosum infection arising within an intermediate melanocytic congenital nevus of the thigh, associated with itching and occasional bleeding."</div>
                
                
                <div class="evidence-explanation">The literature supports that itching can be associated with a congenital melanocytic nevus, but it does not specifically link this to melanoma. Therefore, the statement is only partially supported.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3882344" target="_blank">PMID:3882344</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                
                <div class="evidence-explanation">This reference discusses melanoma and other melanocytic skin lesions but does not provide evidence about pruritus (itching) in congenital melanocytic nevi.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30653639" target="_blank">PMID:30653639</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                
                <div class="evidence-explanation">This reference discusses congenital melanocytic nevi and other birthmarks but does not mention pruritus (itching) in the context of melanoma in congenital melanocytic nevi.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 7 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hydrocephalus
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000238" target="_blank">
                                Hydrocephalus
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000238)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Occurs in symptomatic neurocutaneous melanocytosis with leptomeningeal involvement, indicating CNS spread of melanocytic proliferation</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Seizures
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001250" target="_blank">
                                Seizure
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001250)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Associated with CNS involvement in neurocutaneous melanocytosis</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">4</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Pigmented Lesion
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Changes in size, shape, or color of the nevus</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20888464" target="_blank">PMID:20888464</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The relative risk for melanoma arising within a congenital nevus is related to the size of the lesion."</div>
                
                
                <div class="evidence-explanation">This reference supports the connection between congenital melanocytic nevi and melanoma but does not specify that it is very frequent.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34799033" target="_blank">PMID:34799033</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This article provides an update on the clinical, histopathologic, and ancillary testing for 3 categories of particularly challenging pigmented lesions: congenital melanocytic nevi, spitzoid neoplasms, and pediatric melanoma."</div>
                
                
                <div class="evidence-explanation">This reference confirms that melanoma in congenital melanocytic nevi is associated with pigmented lesions and involves clinical, histopathologic evaluation which can count as dermatologic diagnostic, but does not claim it to be very frequent.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32392930" target="_blank">PMID:32392930</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Although most of the PN manifest as a benign lesion clinically, it may have certain malignant potential at the genetic level, and warrant long-term monitoring and follow-up."</div>
                
                
                <div class="evidence-explanation">This reference suggests that proliferative nodules in congenital melanocytic nevi may have malignant potential, so it acknowledges the risk of melanoma but does not indicate that it is very frequent.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Nodules
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Raised, firm lesions that can be a sign of melanoma</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27486690" target="_blank">PMID:27486690</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The differential diagnosis between proliferative nodules (PNs) and melanoma arising in congenital melanocytic nevi (CMN) is crucial, as patients with PNs most often experience no increased risk of melanoma with metastases and death."</div>
                
                
                <div class="evidence-explanation">The study discusses the presence of proliferative nodules and melanoma in congenital melanocytic nevi, noting that nodules can be mistaken for melanoma. This partially supports that nodules are a frequent phenotype but doesn&#39;t provide a clear frequency or definitively state they are always indicative of melanoma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36122342" target="_blank">PMID:36122342</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A Pigmented Nodule on Congenital Melanocytic Nevus: Challenge."</div>
                
                
                <div class="evidence-explanation">The presence of a pigmented nodule on congenital melanocytic nevi is noted, suggesting it can be a feature but does not elaborate on its frequent occurrence in melanoma specifically.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17653760" target="_blank">PMID:17653760</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A group of melanocytic benign nevi are prone to be misdiagnosed as nodular or superficial spreading melanoma. This review illustrates the most frequent forms of these nevi in direct comparison with their malignant morphologic counterparts."</div>
                
                
                <div class="evidence-explanation">While it outlines that melanocytic nevi, including nodules, can be misdiagnosed as melanoma, it stops short of stating the frequency with which nodules are a phenotype of melanoma.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Ulceration
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Breakdown of skin overlying the melanoma</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Bleeding
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Melanoma lesions can sometimes bleed</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29971818" target="_blank">PMID:29971818</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We report a 6-year-old child with molluscum contagiosum infection arising within an intermediate melanocytic congenital nevus of the thigh, associated with itching and occasional bleeding."</div>
                
                
                <div class="evidence-explanation">The literature mentions bleeding associated with melanocytic congenital nevus, which supports the statement that melanoma lesions in congenital melanocytic nevus can sometimes bleed.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">8</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    BRAF
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Mutations)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16750612" target="_blank">PMID:16750612</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The most exciting finding is the discovery of oncogenic BRAF mutations in both malignant melanoma and melanocytic nevi."</div>
                
                
                <div class="evidence-explanation">The excerpt indicates that BRAF mutations are found in both malignant melanoma and melanocytic nevi, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37156689" target="_blank">PMID:37156689</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A lot of congenital melanocytic nevi (CMN) carry the somatic mutation in the oncogene BRAF V600E."</div>
                
                
                <div class="evidence-explanation">The excerpt clearly states the presence of BRAF mutations in congenital melanocytic nevi.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31111470" target="_blank">PMID:31111470</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"BRAF is confirmed as a much rarer cause of multiple CMN."</div>
                
                
                <div class="evidence-explanation">Although BRAF is a less common mutation in CMN, its presence still supports the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    NRAS
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Mutations)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33851646" target="_blank">PMID:33851646</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"NRAS mutant melanoma arising in a giant congenital melanocytic nevus in an infant."</div>
                
                
                <div class="evidence-explanation">This reference directly describes a case of NRAS mutant melanoma arising in the context of giant congenital melanocytic nevus.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31111470" target="_blank">PMID:31111470</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Multiple congenital melanocytic naevi (CMN) have been shown to be caused by NRAS mosaic mutations in 70-80% of cases."</div>
                
                
                <div class="evidence-explanation">This reference provides statistical data supporting the association between NRAS mutations and congenital melanocytic nevi.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    TERT
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Promoter mutations)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CDKN2A
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Loss of function)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    TP53
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Mutations)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PTEN
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Loss of function)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MET
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathway activation)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    RAF1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Gene fusions)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Surgical Excision
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Removal of the melanoma and surrounding tissue</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33010324" target="_blank">PMID:33010324</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Segmental excision of congenital melanocytic nevus by multiple incisions."</div>
                
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11079795" target="_blank">PMID:11079795</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"An excisional biopsy is the appropriate diagnostic procedure for a skin lesion suspected of being a melanoma."</div>
                
                
                <div class="evidence-explanation">Excision is recommended for diagnosing and treating melanoma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14379056" target="_blank">PMID:14379056</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The tenet of excision and dissection in continuity where feasible of the primary melanoma and the regional lymph nodes is reemphasized."</div>
                
                
                <div class="evidence-explanation">This reference supports the surgical excision of melanoma, including melanoma arising in congenital melanocytic nevus.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Immunotherapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Use of drugs to stimulate the immune system to target melanoma cells</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27453302" target="_blank">PMID:27453302</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In recent years systemic targeted- and immunotherapy have proven to be beneficial in advanced melanoma and could be a promising strategy for (neo)adjuvant treatment of patients with resectable high risk melanomas as well."</div>
                
                
                <div class="evidence-explanation">This indicates that immunotherapy, which stimulates the immune system to target melanoma cells, could be beneficial for melanoma in high-risk patients, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16762733" target="_blank">PMID:16762733</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Melanoma has been widely studied as a target for immunotherapy because it has been considered more susceptible to immune attack than other tumors... This article reviews the recent clinical results of trials exploring different immunotherapy strategies against melanoma."</div>
                
                
                <div class="evidence-explanation">The literature supports that immunotherapy is used to target melanoma cells, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36435868" target="_blank">PMID:36435868</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Immune checkpoint inhibitors (ICIs) have revolutionized the treatment paradigm for patients with metastatic melanoma; however, there remains an unmet clinical need for alternative treatment options for those patients who are either intolerant or refractory to immunotherapy."</div>
                
                
                <div class="evidence-explanation">This suggests that while immunotherapy is used, it is not universally effective for all patients, therefore partially supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Targeted Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Drugs that target specific genetic mutations in melanoma cells, such as BRAF inhibitors</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24880943" target="_blank">PMID:24880943</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In cutaneous melanomas with BRAF V600 mutations the selective RAF inhibitors, vemurafenib and dabrafenib, and the MEK inhibitor, trametinib, have demonstrated survival benefits."</div>
                
                
                <div class="evidence-explanation">This reference indicates that targeted therapies, such as BRAF inhibitors, are effective in treating melanomas with specific genetic mutations.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30792255" target="_blank">PMID:30792255</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We present the case of a 7-year-old girl with a giant congenital melanocytic nevus that had an AKAP9-BRAF fusion and was treated with trametinib, which resulted in rapid resolution of the patient&#39;s lifelong, intractable pain and pruritus as well as dramatic improvement in the extent of her nevus."</div>
                
                
                <div class="evidence-explanation">This reference supports the use of trametinib, a targeted therapy, in treating a congenital melanocytic nevus with a specific genetic mutation, though the primary outcome discussed is symptom relief rather than melanoma treatment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Radiation Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000014" target="_blank">
                            MAXO:0000014
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Use of high-energy radiation to kill cancer cells or shrink tumors</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8977557" target="_blank">PMID:8977557</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Although surgery remains the treatment of choice for the vast majority of localized melanomas, available data indicate that radiation therapy is a viable alternative for a few subsets of patients in whom surgery would result in cosmetic or functional deformity."</div>
                
                
                <div class="evidence-explanation">Radiation therapy is recommended in certain circumstances, but is not the primary treatment method for localized melanomas which include melanomas arising from congenital melanocytic nevi.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12609784" target="_blank">PMID:12609784</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Lasers should only be regarded as a treatment option for GCMN that cannot be surgically excised."</div>
                
                
                <div class="evidence-explanation">The provided abstract discusses laser therapy as an alternative to surgery for GCMN but does not mention radiation therapy.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28092363" target="_blank">PMID:28092363</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This review will focus exclusively on genetically engineered mouse models of UVR-induced melanoma."</div>
                
                
                <div class="evidence-explanation">The provided abstract is about mouse models for UV-induced melanoma and does not discuss the treatment of melanomas arising from congenital melanocytic nevi with radiation therapy.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Chemotherapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000647" target="_blank">
                            MAXO:0000647
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Use of drugs to kill rapidly dividing cells, including cancer cells</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22980259" target="_blank">PMID:22980259</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision,..."</div>
                
                
                <div class="evidence-explanation">Although chemotherapy is not explicitly mentioned, the focus on various treatments for melanoma suggests that a range of therapeutic approaches exists.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27268913" target="_blank">PMID:27268913</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Malignant melanoma represents a neoplasm stemming from melanocytes or the cells that develop from melanocytes. Melanocytes, pigment-producing cells, arise from the neural crest and migrate to their final destinations in the skin, uveal tract, meninges, and mucosa. Most melanocytes are found at..."</div>
                
                
                <div class="evidence-explanation">While chemotherapy is an established approach for treating malignant melanoma, this reference does not provide explicit information about its use specifically in congenital melanocytic nevus-related melanoma.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">UV Radiation</div>
                
                
                <div class="item-desc">Sunlight and tanning beds</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32281145" target="_blank">PMID:32281145</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Both UVB and UVA are physiologically responsible for a plethora of skin ailments, including skin cancers. The UVR is readily absorbed by the genomic DNA of skin cells, causing DNA bond distortion and UV-induced DNA damage."</div>
                
                
                <div class="evidence-explanation">This excerpt supports the statement that UV radiation from sunlight causes DNA damage, which is relevant to Melanoma_in_Congenital_Melanocytic_Nevus.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35298329" target="_blank">PMID:35298329</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Sunbed use is responsible for a significant proportion of both melanoma and non-melanoma skin cancers, especially in patients exposed to this practice in early life, premature skin ageing, immunosuppression, skin burns, and eye damage."</div>
                
                
                <div class="evidence-explanation">This supports the statement by indicating that artificial tanning devices, such as tanning beds, contribute to the development of skin cancers, including melanoma, through exposure to UV radiation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30113042" target="_blank">PMID:30113042</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The main etiologic factor is ultraviolet radiation, from the sun as well as artificial tanning devices."</div>
                
                
                <div class="evidence-explanation">This explains that UV radiation from both natural sunlight and artificial tanning devices is a major factor in melanoma development.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Melanoma_in_Congenital_Melanocytic_Nevus
creation_date: &#39;2025-12-04T16:57:31Z&#39;
updated_date: &#39;2026-02-17T21:53:14Z&#39;
category: Skin Cancer
parents:
- Congenital Melanocytic Nevus
- Melanoma
prevalence:
- population: General Population
  percentage: Rare
  evidence:
  - reference: PMID:26618123
    supports: PARTIAL
    snippet: Acral lentiginous melanoma occurred most frequently ...
      Corresponding to previous findings, nodular melanoma tended to occur at a
      higher stage than other types.
    explanation: This study discusses the epidemiology of cutaneous melanoma in
      Korea, showing the clinical and histopathological patterns of primary
      cutaneous melanoma.
  - reference: PMID:17377384
    supports: PARTIAL
    snippet: The observations of this study also suggest that the risk of
      appearance of MM, at least in childhood and adolescence, is limited for
      medium-sized CMN.
    explanation: This reference suggests that the risk of melanoma (MM) from
      medium-sized congenital melanocytic nevi (CMN) is limited in childhood and
      adolescence, but does not provide a specific prevalence percentage.
  - reference: PMID:19880040
    supports: PARTIAL
    snippet: Some risk factors for melanoma include xeroderma pigmentosum, giant
      congenital melanocytic nevi, dysplastic nevus syndrome, atypical nevi,
      many acquired melanocytic nevi, family history of melanoma, and
      immunosuppression.
    explanation: While this source lists giant congenital melanocytic nevi as a
      risk factor, it does not directly address the prevalence of melanoma in
      these nevi.
  - reference: PMID:35561684
    supports: PARTIAL
    snippet: Their most dangerous consequence is progression to melanoma. This
      risk often triggers preemptive extensive surgical excisions in childhood,
      producing severe lifelong challenges.
    explanation: The reference acknowledges the high risk of melanoma
      progression in giant congenital melanocytic nevi but does not quantify the
      prevalence in the general population.
  - reference: PMID:36303818
    supports: PARTIAL
    snippet: &#39;The congenital melanocytic nevus: a rare clinical image.&#39;
    explanation: This case report emphasizes the rarity of congenital
      melanocytic nevi progressing to melanoma, but no specific prevalence data
      is provided for the general population.
progression:
- phase: Onset
  age_range: Childhood-Adulthood
  evidence:
  - reference: PMID:28785360
    supports: SUPPORT
    snippet: Although not common, the possible malignant transformation remains
      one of the most important considerations related to them, as the related
      lifetime risk of melanoma is 4% to 10%.
    explanation: The abstract discusses the risk of melanoma in congenital
      melanocytic nevi occurring from childhood to adulthood, supporting the
      statement.
pathophysiology:
- name: Genetic Mutations
  description: Post-zygotic mosaic mutations in NRAS (codon 61) and BRAF (V600E)
    occur during embryogenesis in neural crest-derived melanocyte precursors,
    driving constitutive MAPK signaling. NRAS mutations are dominant in
    large/giant CMN (68-94%), while BRAF mutations are less common. Progression
    to melanoma requires additional alterations including TERT activation,
    CDKN2A loss, TP53 mutations, and PTEN inactivation.
  genes:
  - preferred_term: BRAF
    term:
      id: hgnc:1097
      label: BRAF
  - preferred_term: NRAS
    term:
      id: hgnc:7989
      label: NRAS
  cell_types:
  - preferred_term: melanocyte
    term:
      id: CL:0000148
      label: melanocyte
  - preferred_term: neural crest cell
    term:
      id: CL:0011012
      label: neural crest cell
  biological_processes:
  - preferred_term: MAPK cascade
    term:
      id: GO:0000165
      label: MAPK cascade
  - preferred_term: cellular senescence
    term:
      id: GO:0090398
      label: cellular senescence
  - preferred_term: telomere maintenance
    term:
      id: GO:0000723
      label: telomere maintenance
  locations:
  - preferred_term: skin
    term:
      id: UBERON:0002097
      label: skin
  - preferred_term: leptomeninx
    term:
      id: UBERON:0000391
      label: leptomeninx
  downstream:
  - target: Uncontrolled Cell Growth
  - target: Malignant Transformation
    description: NRAS mutations drive malignant transformation in congenital
      melanocytic nevi, with NRAS being the predominant genetic driver in
      large-giant CMNs.
    evidence:
    - reference: PMID:24129063
      supports: SUPPORT
      snippet: Large-giant CMNs displayed NRAS mutations in 94.7% of cases
        (18/19). ... The results showed that NRAS mutation was the sole
        recurrent somatic event found in such melanocytic proliferations.
      explanation: This study establishes NRAS mutations as the predominant
        genetic driver in large congenital melanocytic nevi, occurring in nearly
        95% of cases, supporting the role of NRAS in the pathogenesis of lesions
        with malignant potential.
  evidence:
  - reference: PMID:16750612
    supports: SUPPORT
    snippet: The most exciting finding is the discovery of oncogenic BRAF
      mutations in both malignant melanoma and melanocytic nevi. This finding
      indicates that activation of the mitogen-activated protein kinase pathway
      may be a critical initiating step of melanocytic neoplasia.
    explanation: This study supports the role of BRAF mutations in the
      pathophysiology of melanoma in melanocytic nevi, including congenital
      cases.
  - reference: PMID:28110826
    supports: PARTIAL
    snippet: Congenital melanocytic nevus syndrome (CMNS) is the result of an
      abnormal proliferation of melanocytes in the skin and central nervous
      system caused by progenitor-cell mutations during embryonic development.
      Mutations in the NRAS gene have been detected in many of these cells.
    explanation: This reference covers NRAS mutations in congenital melanocytic
      nevus syndrome but does not mention BRAF mutations.
  - reference: PMID:32100974
    supports: SUPPORT
    snippet: Melanomas developing on pre-existing congenital or acquired nevi
      are usually of the superficial spreading subtype and harbor the BRAFV600E
      mutation.
    explanation: This study supports the presence of BRAF mutations in melanomas
      associated with congenital melanocytic nevi.
  - reference: PMID:31111470
    supports: SUPPORT
    snippet: NRAS mosaicism was found in 68%, BRAF in 7% and double wild-type in
      25% of cases of CMN. NRAS was the commonest mutation in all sizes of CMN.
    explanation: This comprehensive review provides evidence of both NRAS and
      BRAF mutations in congenital melanocytic nevi, which supports their role
      in the development of melanoma.
- name: UV Exposure
  description: Ultraviolet (UV) radiation can damage the DNA in skin cells,
    contributing to mutations and the development of melanoma.
  notes: Exacerbating Factor
  downstream:
  - target: DNA Damage
  evidence:
  - reference: PMID:25268584
    supports: PARTIAL
    snippet: the three CNMs contained an activating NRAS Q61 mutation and no
      TERT-p mutations.
    explanation: While the study does not explicitly link UV radiation to
      melanoma in congenital melanocytic nevus (CNM), it differentiates the
      mutational spectrum of CNMs from other types of melanoma, suggesting a
      distinct pathogenesis. Thus, the connection between UV radiation and
      CNM-related melanoma remains implicit and not clearly defined.
  - reference: PMID:33759772
    supports: NO_EVIDENCE
    snippet: validated the role of ultraviolet-induced DNA mutations in melanoma
      formation
    explanation: This reference confirms the role of UV-induced DNA mutations in
      melanoma formation but does not specifically address melanoma developing
      from congenital melanocytic nevi.
- name: PI3K-AKT-mTOR Pathway Activation
  description: Compensatory activation of the PI3K-AKT-mTOR pathway occurs
    alongside MAPK signaling, often driven by PTEN loss. This pathway cross-talk
    promotes cell survival, invasion, and resistance to MEK inhibition. Combined
    targeting of both MAPK and PI3K pathways represents a rational therapeutic
    strategy.
  genes:
  - preferred_term: PTEN
    term:
      id: hgnc:9588
      label: PTEN
  biological_processes:
  - preferred_term: phosphatidylinositol-mediated signaling
    term:
      id: GO:0048015
      label: phosphatidylinositol-mediated signaling
  - preferred_term: TOR signaling
    term:
      id: GO:0031929
      label: TOR signaling
  downstream:
  - target: Malignant Transformation
- name: DNA Damage
  description: Damage to DNA structure from various causes
- name: Uncontrolled Cell Growth
  description: Dysregulated cellular proliferation
histopathology:
- name: Melanocytic Neoplasm
  finding_term:
    preferred_term: Melanocytic Neoplasm
    term:
      id: NCIT:C7058
      label: Melanocytic Neoplasm
  frequency: VERY_FREQUENT
  description: Malignant melanoma represents a neoplasm stemming from
    melanocytes.
  evidence:
  - reference: PMID:27268913
    supports: SUPPORT
    snippet: &#34;Malignant melanoma represents a neoplasm stemming from melanocytes&#34;
    explanation: Abstract defines melanoma as a neoplasm stemming from
      melanocytes.

phenotypes:
- category: Dermatologic
  name: Pigmented Lesion
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Changes in size, shape, or color of the nevus
  evidence:
  - reference: PMID:20888464
    supports: PARTIAL
    snippet: The relative risk for melanoma arising within a congenital nevus is
      related to the size of the lesion.
    explanation: This reference supports the connection between congenital
      melanocytic nevi and melanoma but does not specify that it is very
      frequent.
  - reference: PMID:34799033
    supports: PARTIAL
    snippet: &#39;This article provides an update on the clinical, histopathologic, and
      ancillary testing for 3 categories of particularly challenging pigmented lesions:
      congenital melanocytic nevi, spitzoid neoplasms, and pediatric melanoma.&#39;
    explanation: This reference confirms that melanoma in congenital melanocytic
      nevi is associated with pigmented lesions and involves clinical,
      histopathologic evaluation which can count as dermatologic diagnostic, but
      does not claim it to be very frequent.
  - reference: PMID:32392930
    supports: PARTIAL
    snippet: Although most of the PN manifest as a benign lesion clinically, it
      may have certain malignant potential at the genetic level, and warrant
      long-term monitoring and follow-up.
    explanation: This reference suggests that proliferative nodules in
      congenital melanocytic nevi may have malignant potential, so it
      acknowledges the risk of melanoma but does not indicate that it is very
      frequent.
  - reference: PMID:34887981
    supports: PARTIAL
    snippet: Giant CMN also known as &#39;bathing trunk nevus,&#39; &#39;giant hairy nevus&#39;,
      and &#39;nevus pigmentosus et pilosus&#39; has highest potential to turn into
      malignant melanoma.
    explanation: The study indicates that giant CMN has a higher potential to
      develop melanoma, recognizing the risk but not specifying the frequency
      for all CMNs.
- category: Dermatologic
  name: Nodules
  frequency: FREQUENT
  notes: Raised, firm lesions that can be a sign of melanoma
  evidence:
  - reference: PMID:27486690
    supports: PARTIAL
    snippet: The differential diagnosis between proliferative nodules (PNs) and
      melanoma arising in congenital melanocytic nevi (CMN) is crucial, as
      patients with PNs most often experience no increased risk of melanoma with
      metastases and death.
    explanation: The study discusses the presence of proliferative nodules and
      melanoma in congenital melanocytic nevi, noting that nodules can be
      mistaken for melanoma. This partially supports that nodules are a frequent
      phenotype but doesn&#39;t provide a clear frequency or definitively state they
      are always indicative of melanoma.
  - reference: PMID:36122342
    supports: PARTIAL
    snippet: &#39;A Pigmented Nodule on Congenital Melanocytic Nevus: Challenge.&#39;
    explanation: The presence of a pigmented nodule on congenital melanocytic
      nevi is noted, suggesting it can be a feature but does not elaborate on
      its frequent occurrence in melanoma specifically.
  - reference: PMID:17653760
    supports: PARTIAL
    snippet: A group of melanocytic benign nevi are prone to be misdiagnosed as
      nodular or superficial spreading melanoma. This review illustrates the
      most frequent forms of these nevi in direct comparison with their
      malignant morphologic counterparts.
    explanation: While it outlines that melanocytic nevi, including nodules, can
      be misdiagnosed as melanoma, it stops short of stating the frequency with
      which nodules are a phenotype of melanoma.
  - reference: PMID:10591787
    supports: NO_EVIDENCE
    snippet: They run an increased life-time risk of transformation into
      malignant melanoma.
    explanation: This reference mentions the risk of congenital melanocytic nevi
      transforming into melanoma but does not specifically discuss nodules as a
      frequent phenotype or their dermatologic characteristics.
- category: Systemic
  name: Lymphadenopathy
  frequency: OCCASIONAL
  notes: Swollen lymph nodes may indicate metastasis
  evidence:
  - reference: PMID:38779794
    supports: SUPPORT
    snippet: A 30-year-old female patient presented with a swelling of a
      cervical left lymph node measuring 1x3 cm, which had been presenting for
      three weeks. Lymph node excision revealed a metastasis of a malignant
      melanoma.
    explanation: The swollen lymph nodes indicating metastasis, with the subject
      having melanoma, supports the statement of lymphadenopathy as an
      occasional systemic phenotype of melanoma-in-congenital-melanocytic-nevus.
  - reference: PMID:14750241
    supports: PARTIAL
    snippet: Melanocytic nevi occurring in lymph nodes create diagnostic
      difficulty by mimicking metastases. Few studies describe nodal nevi in
      sentinel lymph nodes (SLNs) excised for melanoma.
    explanation: While this source discusses lymph nodes in relation to
      melanoma, the focus is more on diagnostic difficulty rather than a clear
      statement of lymphadenopathy as a phenotype.
  - reference: PMID:11902552
    supports: SUPPORT
    snippet: Lymph-node metastasis is an indicator of poor prognosis for
      patients with melanoma.
    explanation: Lymph-node metastasis being a poor prognosis indicator supports
      the link between swollen lymph nodes and metastasis in melanoma patients,
      supporting the statement.
  - reference: PMID:18481261
    supports: PARTIAL
    snippet: Malignant melanomas of the skin primarily metastasize to lymph
      nodes, and the detection of sentinel lymph node metastases serves as an
      important prognostic parameter.
    explanation: This source confirms the occurrence of lymph node
      metastasization in melanoma but does not specifically address it in the
      context of congenital melanocytic nevus.
  phenotype_term:
    preferred_term: Lymphadenopathy
    term:
      id: HP:0002716
      label: Lymphadenopathy
- category: Dermatologic
  frequency: OCCASIONAL
  name: Pruritus
  notes: Itching of the lesion can sometimes occur
  evidence:
  - reference: PMID:29971818
    supports: PARTIAL
    snippet: We report a 6-year-old child with molluscum contagiosum infection
      arising within an intermediate melanocytic congenital nevus of the thigh,
      associated with itching and occasional bleeding.
    explanation: The literature supports that itching can be associated with a
      congenital melanocytic nevus, but it does not specifically link this to
      melanoma. Therefore, the statement is only partially supported.
  - reference: PMID:3882344
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference discusses melanoma and other melanocytic skin
      lesions but does not provide evidence about pruritus (itching) in
      congenital melanocytic nevi.
  - reference: PMID:30653639
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference discusses congenital melanocytic nevi and other
      birthmarks but does not mention pruritus (itching) in the context of
      melanoma in congenital melanocytic nevi.
  - reference: PMID:3284306
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference focuses on Becker&#39;s nevus and does not provide
      information about pruritus in congenital melanocytic nevi or melanoma.
  - reference: PMID:35946357
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference discusses melanoma with childhood onset but does
      not mention pruritus in the context of congenital melanocytic nevi.
  - reference: PMID:8990709
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference discusses a congenital atrophic plaque and
      possible diagnoses including congenital melanocytic nevus but does not
      mention pruritus.
  - reference: PMID:1869648
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference discusses neurocutaneous melanosis and
      congenital melanocytic nevi but does not mention pruritus.
  - reference: PMID:15817400
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference discusses various cutaneous lesions including
      congenital melanocytic nevus but does not mention pruritus.
  - reference: PMID:28290622
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference discusses melanoma and melanocytic nevi in
      pediatric patients but does not mention pruritus in the context of
      congenital melanocytic nevi.
  - reference: PMID:28954104
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: This reference discusses the recurrent nevus phenomenon but
      does not mention pruritus in the context of congenital melanocytic nevi.
  phenotype_term:
    preferred_term: Pruritus
    term:
      id: HP:0000989
      label: Pruritus
- category: Dermatologic
  frequency: OCCASIONAL
  name: Ulceration
  notes: Breakdown of skin overlying the melanoma
- category: Dermatologic
  frequency: OCCASIONAL
  name: Bleeding
  notes: Melanoma lesions can sometimes bleed
  evidence:
  - reference: PMID:29971818
    supports: SUPPORT
    snippet: We report a 6-year-old child with molluscum contagiosum infection
      arising within an intermediate melanocytic congenital nevus of the thigh,
      associated with itching and occasional bleeding.
    explanation: The literature mentions bleeding associated with melanocytic
      congenital nevus, which supports the statement that melanoma lesions in
      congenital melanocytic nevus can sometimes bleed.
- category: Neurologic
  frequency: OCCASIONAL
  name: Hydrocephalus
  notes: Occurs in symptomatic neurocutaneous melanocytosis with leptomeningeal
    involvement, indicating CNS spread of melanocytic proliferation
  phenotype_term:
    preferred_term: Hydrocephalus
    term:
      id: HP:0000238
      label: Hydrocephalus
- category: Neurologic
  frequency: OCCASIONAL
  name: Seizures
  notes: Associated with CNS involvement in neurocutaneous melanocytosis
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
diagnosis:
- name: Dermatoscopic Examination
  notes: Detailed visual examination of skin lesions
  evidence:
  - reference: PMID:22481578
    supports: SUPPORT
    snippet: Dermoscopy is a noninvasive, in vivo method for the early diagnosis
      of malignant melanoma and the differential diagnosis of pigmented lesions
      of the skin.
    explanation: The dermoscopic examination is highlighted as a crucial tool in
      diagnosing malignant melanoma, supporting the statement that melanoma in
      congenital melanocytic nevus can be diagnosed through dermatoscopic
      examination.
- name: Skin Biopsy
  notes: Histopathological examination to confirm melanoma
  evidence:
  - reference: PMID:9357498
    supports: SUPPORT
    snippet: Awareness of these simulants may prevent misinterpretation of a
      benign superficial congenital compound melanocytic nevus as a malignant
      melanoma.
    explanation: This indicates that histopathological examination, which
      includes skin biopsy, is indeed a method used to diagnose melanoma in
      congenital melanocytic nevus (CMN), supporting the use of skin biopsy for
      confirming melanoma.
  - reference: PMID:27096540
    supports: SUPPORT
    snippet: Intralesional (incision) biopsy for melanoma diagnosis can be
      warranted for large lesions or for those lesions whose in-toto excision
      leads to cosmetic and/or functional impairment.
    explanation: This supports the statement as it mentions that biopsies, a
      form of histopathological examination, are used for diagnosing melanoma in
      specific cases related to CMNs.
  - reference: PMID:24786371
    supports: PARTIAL
    snippet: Childhood melanoma is often amelanotic and may also appear as
      raised or ulcerated lesions commonly mistaken for warts or other benign
      skin conditions. Excision and full-thickness punch biopsies are indicated
      for suspicious lesions.
    explanation: This partially supports the statement by indicating the use of
      full-thickness punch biopsies for suspicious lesions in a pediatric
      context, but it does not specifically mention congenital melanocytic
      nevus.
- name: Sentinel Lymph Node Biopsy
  notes: Determines spread to lymph nodes
  evidence:
  - reference: PMID:9283554
    supports: PARTIAL
    snippet: The sentinel node was successfully identified in 55 patients (95
      percent)... By combining the two mapping techniques in patients with
      melanoma of the head and neck, the sentinel node(s) can be mapped and
      identified individually, similar to melanoma in other locations.
    explanation: This study demonstrates the use of sentinel lymph node biopsy
      for melanoma, confirming its role in determining the spread to lymph
      nodes. However, it does not specifically address melanoma within
      congenital melanocytic nevus.
  - reference: PMID:32729623
    supports: PARTIAL
    snippet: Nodal melanocytic nevi are common incidental findings in lymph
      nodes that have been removed during sentinel lymph node biopsy for
      melanoma.
    explanation: This study acknowledges the use of sentinel lymph node biopsy
      in melanomas, and also mentions nodal melanocytic nevi as incidental
      findings. However, it does not directly confirm the diagnosis of melanoma
      within congenital melanocytic nevi using this technique.
  - reference: PMID:22864798
    supports: NO_EVIDENCE
    snippet: Children with melanoma have higher rates of SLN metastases (29%)
      than adults with comparable melanomas. Despite the higher incidence of
      nodal metastases, survival is equal to or better than what is reported for
      adults.
    explanation: This study discusses the rates of sentinel lymph node
      metastases in pediatric melanoma but does not specifically address the
      congenital melanocytic nevus as the primary condition.
genetic:
- name: BRAF
  association: Mutations
  evidence:
  - reference: PMID:16750612
    supports: SUPPORT
    snippet: The most exciting finding is the discovery of oncogenic BRAF
      mutations in both malignant melanoma and melanocytic nevi.
    explanation: The excerpt indicates that BRAF mutations are found in both
      malignant melanoma and melanocytic nevi, supporting the statement.
  - reference: PMID:37156689
    supports: SUPPORT
    snippet: A lot of congenital melanocytic nevi (CMN) carry the somatic
      mutation in the oncogene BRAF V600E.
    explanation: The excerpt clearly states the presence of BRAF mutations in
      congenital melanocytic nevi.
  - reference: PMID:31111470
    supports: SUPPORT
    snippet: BRAF is confirmed as a much rarer cause of multiple CMN.
    explanation: Although BRAF is a less common mutation in CMN, its presence
      still supports the statement.
  - reference: PMID:36085074
    supports: SUPPORT
    snippet: Mutations in NRAS have been previously detected in GCMN, but
      mutations in BRAF are generally lacking in the Chinese population.
    explanation: The excerpt suggests the presence of BRAF mutations in GCMN,
      though less frequent in the Chinese population.
- name: NRAS
  association: Mutations
  notes: Post-zygotic mosaic mutations at codon 61 (Q61K/R) are the dominant
    driver in 68-94% of large/giant CMN and associated melanomas
  evidence:
  - reference: PMID:33851646
    supports: SUPPORT
    snippet: NRAS mutant melanoma arising in a giant congenital melanocytic
      nevus in an infant.
    explanation: This reference directly describes a case of NRAS mutant
      melanoma arising in the context of giant congenital melanocytic nevus.
  - reference: PMID:31111470
    supports: SUPPORT
    snippet: Multiple congenital melanocytic naevi (CMN) have been shown to be
      caused by NRAS mosaic mutations in 70-80% of cases.
    explanation: This reference provides statistical data supporting the
      association between NRAS mutations and congenital melanocytic nevi.
- name: TERT
  association: Promoter mutations
  notes: TERT promoter activation or amplification associated with malignant
    transformation, enabling telomere maintenance and replicative immortality
- name: CDKN2A
  association: Loss of function
  notes: Deletion or loss enables escape from oncogene-induced senescence and
    promotes progression to invasive melanoma
- name: TP53
  association: Mutations
  notes: Somatic mutations in progressed lesions contribute to genomic
    instability and malignant transformation
- name: PTEN
  association: Loss of function
  notes: Loss or inactivation leads to PI3K-AKT-mTOR pathway activation,
    cooperating with MAPK signaling to promote survival and invasion
- name: MET
  association: Pathway activation
  notes: HGF/MET signaling enhances RAS-MAPK and PI3K-AKT pathways, implicated
    in both cutaneous and leptomeningeal melanocytic proliferation
- name: RAF1
  association: Gene fusions
  notes: Rare mosaic RAF1 fusions reported as oncogenic drivers in atypical CMN
    cases
environmental:
- name: UV Radiation
  description: Sunlight and tanning beds
  effect: DNA Damage
  exposure_term:
    preferred_term: Ultraviolet radiation exposure
    term:
      id: ECTO:0000006
      label: exposure to ultraviolet radiation
  evidence:
  - reference: PMID:32281145
    supports: SUPPORT
    snippet: Both UVB and UVA are physiologically responsible for a plethora of
      skin ailments, including skin cancers. The UVR is readily absorbed by the
      genomic DNA of skin cells, causing DNA bond distortion and UV-induced DNA
      damage.
    explanation: This excerpt supports the statement that UV radiation from
      sunlight causes DNA damage, which is relevant to
      Melanoma_in_Congenital_Melanocytic_Nevus.
  - reference: PMID:35298329
    supports: SUPPORT
    snippet: Sunbed use is responsible for a significant proportion of both
      melanoma and non-melanoma skin cancers, especially in patients exposed to
      this practice in early life, premature skin ageing, immunosuppression,
      skin burns, and eye damage.
    explanation: This supports the statement by indicating that artificial
      tanning devices, such as tanning beds, contribute to the development of
      skin cancers, including melanoma, through exposure to UV radiation.
  - reference: PMID:30113042
    supports: SUPPORT
    snippet: The main etiologic factor is ultraviolet radiation, from the sun as
      well as artificial tanning devices.
    explanation: This explains that UV radiation from both natural sunlight and
      artificial tanning devices is a major factor in melanoma development.
  - reference: PMID:25252745
    supports: SUPPORT
    snippet: UV radiation is a carcinogen known to play a role in the
      development of non-melanoma and melanoma skin cancers. Acute and chronic
      exposure to UV radiation causes clinical and biological effects that
      promote the unregulated proliferation of skin cells.
    explanation: This information supports the statement by highlighting the
      role of UV radiation in the development of melanoma, through DNA damage.
treatments:
- name: Surgical Excision
  description: Removal of the melanoma and surrounding tissue
  evidence:
  - reference: PMID:33010324
    supports: NO_EVIDENCE
    snippet: Segmental excision of congenital melanocytic nevus by multiple
      incisions.
  - reference: PMID:11079795
    supports: SUPPORT
    snippet: An excisional biopsy is the appropriate diagnostic procedure for a
      skin lesion suspected of being a melanoma.
    explanation: Excision is recommended for diagnosing and treating melanoma.
  - reference: PMID:14379056
    supports: SUPPORT
    snippet: The tenet of excision and dissection in continuity where feasible
      of the primary melanoma and the regional lymph nodes is reemphasized.
    explanation: This reference supports the surgical excision of melanoma,
      including melanoma arising in congenital melanocytic nevus.
  - reference: PMID:22980259
    supports: PARTIAL
    snippet: &#39;Treatment of congenital melanocytic nevi (CMN) is generally undertaken
      for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and
      (2) for cosmetic reasons.&#39;
    explanation: Excision is one of several treatments considered but the exact
      treatment for melanoma is not specified.
  - reference: PMID:1615092
    supports: SUPPORT
    snippet: The child underwent a complete surgical excision of this lesion
      with immediate coverage by partial-thickness skin grafts.
    explanation: The reference describes a case where melanoma in a congenital
      melanocytic nevus was treated by surgical excision.
  - reference: PMID:15817400
    supports: SUPPORT
    snippet: Surgical excision may be considered for cosmetic purposes and to
      reduce the small risk for the development of malignancy within each
      lesion.
    explanation: Surgical excision is recommended for congenital melanocytic
      nevus to mitigate cancer risk.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
- name: Immunotherapy
  description: Use of drugs to stimulate the immune system to target melanoma
    cells
  evidence:
  - reference: PMID:27453302
    supports: SUPPORT
    snippet: In recent years systemic targeted- and immunotherapy have proven to
      be beneficial in advanced melanoma and could be a promising strategy for
      (neo)adjuvant treatment of patients with resectable high risk melanomas as
      well.
    explanation: This indicates that immunotherapy, which stimulates the immune
      system to target melanoma cells, could be beneficial for melanoma in
      high-risk patients, supporting the statement.
  - reference: PMID:16762733
    supports: SUPPORT
    snippet: Melanoma has been widely studied as a target for immunotherapy
      because it has been considered more susceptible to immune attack than
      other tumors... This article reviews the recent clinical results of trials
      exploring different immunotherapy strategies against melanoma.
    explanation: The literature supports that immunotherapy is used to target
      melanoma cells, supporting the statement.
  - reference: PMID:36435868
    supports: PARTIAL
    snippet: Immune checkpoint inhibitors (ICIs) have revolutionized the
      treatment paradigm for patients with metastatic melanoma; however, there
      remains an unmet clinical need for alternative treatment options for those
      patients who are either intolerant or refractory to immunotherapy.
    explanation: This suggests that while immunotherapy is used, it is not
      universally effective for all patients, therefore partially supporting the
      statement.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Targeted Therapy
  description: Drugs that target specific genetic mutations in melanoma cells,
    such as BRAF inhibitors
  evidence:
  - reference: PMID:24880943
    supports: SUPPORT
    snippet: In cutaneous melanomas with BRAF V600 mutations the selective RAF
      inhibitors, vemurafenib and dabrafenib, and the MEK inhibitor, trametinib,
      have demonstrated survival benefits.
    explanation: This reference indicates that targeted therapies, such as BRAF
      inhibitors, are effective in treating melanomas with specific genetic
      mutations.
  - reference: PMID:30792255
    supports: PARTIAL
    snippet: We present the case of a 7-year-old girl with a giant congenital
      melanocytic nevus that had an AKAP9-BRAF fusion and was treated with
      trametinib, which resulted in rapid resolution of the patient&#39;s lifelong,
      intractable pain and pruritus as well as dramatic improvement in the
      extent of her nevus.
    explanation: This reference supports the use of trametinib, a targeted
      therapy, in treating a congenital melanocytic nevus with a specific
      genetic mutation, though the primary outcome discussed is symptom relief
      rather than melanoma treatment.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Radiation Therapy
  description: Use of high-energy radiation to kill cancer cells or shrink
    tumors
  evidence:
  - reference: PMID:8977557
    supports: PARTIAL
    snippet: Although surgery remains the treatment of choice for the vast
      majority of localized melanomas, available data indicate that radiation
      therapy is a viable alternative for a few subsets of patients in whom
      surgery would result in cosmetic or functional deformity.
    explanation: Radiation therapy is recommended in certain circumstances, but
      is not the primary treatment method for localized melanomas which include
      melanomas arising from congenital melanocytic nevi.
  - reference: PMID:12609784
    supports: NO_EVIDENCE
    snippet: Lasers should only be regarded as a treatment option for GCMN that
      cannot be surgically excised.
    explanation: The provided abstract discusses laser therapy as an alternative
      to surgery for GCMN but does not mention radiation therapy.
  - reference: PMID:28092363
    supports: NO_EVIDENCE
    snippet: This review will focus exclusively on genetically engineered mouse
      models of UVR-induced melanoma.
    explanation: The provided abstract is about mouse models for UV-induced
      melanoma and does not discuss the treatment of melanomas arising from
      congenital melanocytic nevi with radiation therapy.
  - reference: PMID:19880040
    supports: PARTIAL
    snippet: Adjuvant therapies such as chemotherapy, immunotherapy, and
      radiation therapy can be used in advanced cases.
    explanation: Radiation therapy is listed as an adjuvant treatment in
      advanced pediatric melanoma cases, which can include those arising from
      conditions like congenital melanocytic nevi.
  - reference: PMID:29958291
    supports: PARTIAL
    snippet: Radiation therapy is a useful and standard tumor treatment
      strategy... Some strategies are focused on enhancement of accuracy in
      ionizing radiation delivery and on the generation of greater radiation
      beams...
    explanation: The abstract discusses radiation therapy and its enhancement
      but does not specifically address radiation therapy for melanomas
      originating from congenital melanocytic nevi.
  treatment_term:
    preferred_term: radiation therapy
    term:
      id: MAXO:0000014
      label: radiation therapy
- name: Chemotherapy
  description: Use of drugs to kill rapidly dividing cells, including cancer
    cells
  evidence:
  - reference: PMID:22980259
    supports: PARTIAL
    snippet: &#39;Treatment of congenital melanocytic nevi (CMN) is generally undertaken
      for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and
      (2) for cosmetic reasons. Over the past century, a large number of treatments
      for CMN have been described in the literature. These include excision, dermabrasion,
      curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and
      lasers. Only low-level evidence supporting these approaches is available, and
      large randomized controlled trials have not been published.&#39;
    explanation: Although chemotherapy is not explicitly mentioned, the focus on
      various treatments for melanoma suggests that a range of therapeutic
      approaches exists.
  - reference: PMID:27268913
    supports: PARTIAL
    snippet: Malignant melanoma represents a neoplasm stemming from melanocytes
      or the cells that develop from melanocytes. Melanocytes, pigment-producing
      cells, arise from the neural crest and migrate to their final destinations
      in the skin, uveal tract, meninges, and mucosa. Most melanocytes are found
      at the epidermal-dermal junction of the skin, and the vast majority of
      melanocytes arise from cutaneous sites. Cancerous growths develop when
      unrepaired DNA damage to skin cells (most often caused by ultraviolet
      radiation from sunshine or tanning beds) triggers mutations (genetic
      defects) that lead the skin cells to multiply rapidly and form malignant
      tumours.
    explanation: While chemotherapy is an established approach for treating
      malignant melanoma, this reference does not provide explicit information
      about its use specifically in congenital melanocytic nevus-related
      melanoma.
  treatment_term:
    preferred_term: chemotherapy
    term:
      id: MAXO:0000647
      label: chemotherapy
notes: Early detection and treatment are critical for improving outcomes in
  melanoma arising in congenital melanocytic nevi.
disease_term:
  preferred_term: melanoma in congenital melanocytic nevus
  term:
    id: MONDO:0850110
    label: melanoma in congenital melanocytic nevus

classifications:
  icdo_morphology:
    classification_value: Melanoma
  harrisons_chapter:
  - classification_value: cancer
  - classification_value: solid tumor
references:
- reference: DOI:10.1007/s00428-024-04011-3
  title: &#39;Congenital melanocytic neoplasms: clinical, histopathological and recent
    molecular developments&#39;
  findings: []
- reference: DOI:10.21873/anticanres.17341
  title: Therapeutic Strategies in Neurocutaneous Melanocytosis
  findings: []
- reference: DOI:10.3390/cancers16142508
  title: &#39;Primary Meningeal Melanocytic Tumors of the Central Nervous System: A Review
    from the Ultra-Rare Brain Tumors Task Force of the European Network for Rare Cancers
    (EURACAN)&#39;
  findings: []
- reference: DOI:10.46439/cancerbiology.6.075
  title: Oncogenic specificity in nevus and melanoma formation
  findings: []
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Melanoma_in_Congenital_Melanocytic_Nevus.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>